-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Rhv3s1ETNH7gos7WSJf6lmv+9qNQbGzTxK5E6lOimWPQtOGFsCWchw8Z+IpZmRQf eAoI8KG997Rv+Y4bw8QKNw== 0001237899-09-000010.txt : 20090224 0001237899-09-000010.hdr.sgml : 20090224 20090224092043 ACCESSION NUMBER: 0001237899-09-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090220 FILED AS OF DATE: 20090224 DATE AS OF CHANGE: 20090224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAKER CHARLES A CENTRAL INDEX KEY: 0001225470 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 09629588 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2009-02-20 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001225470 BAKER CHARLES A 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2009-02-20 4 M 0 10000 7.66 A 10590 D Common Stock 2009-02-20 4 S 0 10000 18.16 D 590 D Non-Qualified Stock Option (right to buy) 7.66 2009-02-20 4 M 0 10000 D 2009-03-01 Common Stock 10000 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). The reporting person sold 10,000 share of Company stock on February 20, 2009 at prices ranging from$18.03 to $18.28. Upon request by the Commission staff, the Company, or a security holder of the Company, we will provide full information regarding the number of shares sold by the reporting person on Febuary 20, 2009 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case. /s/**Charles A. Baker 2009-02-23 -----END PRIVACY-ENHANCED MESSAGE-----